跳至主要内容
临床试验/IRCT20190905044704N1
IRCT20190905044704N1尚未招募3 期

The effect of intermediate dose of heparin solution in the prevention of central vein catheter occlusion on ICU admitted patients

Mashhad University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • All ICU admitted patients who had 3 functional lumen catheter that insert less than 12 hours

排除标准

  • Dialysis and phresis and pulmonary artery catheters and insertable ports
  • Age less than 18 y/o
  • Heparin sensivity and HIT
  • Coagolation system disorder and thrombocytopenia
  • Therapeutic dose of anticoagolant
  • Packed cell or any blood products transfusion
  • If the active lines needed more than 3 time hepparizination were excluded

研究者

相似试验